
According to a survey published at the world’s largest biotech convention in Boston earlier this year, the US is the only country more favorable than Denmark for setting up a biotech cluster.
The extensive analysis ranked 50 countries based on a range of parameters, such as available capital, protection of intellectual property rights, education and work force, political climate and political stability and the role biotech played for the overall economy.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app